Targeting a new regulator of erythropoiesis to alleviate anemia

被引：0
|
作者：
Robert F Paulson
机构：
[1] Robert F. Paulson is at the Center for Molecular Immunology and Infectious Disease,Department of Veterinary and Biomedical Sciences
[2] The Pennsylvania State University,undefined
[3] University Park,undefined
[4] Pennsylvania,undefined
[5] USA.,undefined
来源：
Nature Medicine | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Anemia is a debilitating condition that can be complicated by ineffective erythropoiesis. Two new studies identify GDF11 as a regulator of erythropoiesis and show that its inhibition in mouse models of anemia with ineffective erythropoiesis restores normal erythropoietic differentiation and alleviates anemia (pages 398–407 and 408–414).
引用
收藏
页码：334 / 335
页数：1
相关论文
共 50 条
  • [31] Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease
    Roy, Mrittika
    Saroha, Shaifali
    Sarma, Uddipan
    Sarathy, Harini
    Kumar, Rukmini
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [32] Ineffective Erythropoiesis: Anemia and Iron Overload
    Gupta, Ritama
    Musallam, Khaled M.
    Taher, Ali T.
    Rivella, Stefano
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (02) : 213 - +
  • [33] Identification of the transcription factor MAZ as a regulator of erythropoiesis
    Deen, Darya
    Butter, Falk
    Daniels, Deborah E.
    Ferrer-Vicens, Ivan
    Ferguson, Daniel C. J.
    Holland, Michelle L.
    Samara, Vasiliki
    Sloane-Stanley, Jacqueline A.
    Ayyub, Helena
    Mann, Matthias
    Frayne, Jan
    Garrick, David
    Vernimmen, Douglas
    BLOOD ADVANCES, 2021, 5 (15) : 3002 - 3015
  • [34] IDENTIFICATION OF THE TRANSCRIPTION FACTOR MAZ AS A REGULATOR OF ERYTHROPOIESIS
    Vernimmen, Douglas
    Deen, Darya
    Butter, Falk
    Daniels, Deborah
    Ferguson, Daniel
    Vicens, Ivan Ferrer
    Holland, Michelle
    Samara, Vasiliki
    Sloane-Stanley, Jacqueline
    Ayyub, Helena
    Mann, Matthias
    Frayne, Jan
    Garrick, David
    EXPERIMENTAL HEMATOLOGY, 2021, 100 : S108 - S108
  • [35] Targeting Transferrin Receptor 2: A Novel "Erythropoiesis-Stimulating Approach" in a Model of Anemia of Chronic Kidney Disease
    Olivari, Violante
    Lidonnici, Maria Rosa
    Pettinato, Mariateresa
    Silvestri, Laura
    Ferrari, Giuliana
    Camaschella, Clara
    Nai, Antonella
    BLOOD, 2019, 134
  • [36] Chemotherapy-induced anemia - Blood transfusion, erythropoietin and new erythropoiesis - Stimulating factor
    Untch, M
    von Koch, FE
    Kahlert, S
    Hepp, H
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2002, 62 (02) : 186 - 187
  • [37] Nonregenerative Anemia: Mechanisms of Decreased or Ineffective Erythropoiesis
    Grimes, C. N.
    Fry, M. M.
    VETERINARY PATHOLOGY, 2015, 52 (02) : 298 - 311
  • [38] INHIBITORS OF ERYTHROPOIESIS IN PATIENTS WITH APLASTIC-ANEMIA
    GUDIM, VI
    MOSKALEVA, GP
    IVANOVA, VS
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1974, 77 (07) : 745 - 747
  • [39] Small Molecules Targeting the TLR Pathway Alleviate Anemia in a Zebrafish Model of MDS with Del(5q)
    Rowell, Jasmine
    Pena, Oscar
    Hockings, Catherine
    Bruce, Laura
    Jung, Youngrock
    Virgilio, Maria
    Pietka, Gregorz
    Contento, Gregorio
    Payne, Elspeth M.
    BLOOD, 2016, 128 (22)
  • [40] Mechanisms of regulation of erythropoiesis during hemolytic anemia
    Zyuz'kov G.N.
    Abramova E.V.
    Dygai A.M.
    Gol'dberg E.D.
    Bulletin of Experimental Biology and Medicine, 2004, 138 (4) : 334 - 337
12345